Protecting Australia's intellectual property


Date: 20/06/2002

Protecting and commercialising biotechnological intellectual property poses many questions for Australian researchers. To address this issue, the University of Western Sydney will host a biotechnology commercialisation seminar at Parramatta campus on Tuesday, July 2, 2002.

The seminar aims to inform biotech businesses, industry professionals, researchers and postgraduate students about the latest developments in commercialisation and intellectual property.

Seminar coordinator, Amanda Burdon says many researchers are so focused with their core research that "intellectual property (IP) issues are often considered belatedly rather than as part of a research plan from the outset".

"Our speakers will include Steven Playford from Biotechnology Australia, David Adamthwaite from Baldwin Shelston and Waters, Robert Bosshard from Bosshard Medical, investment analyst John Mulquiney from Nanyang Ventures and the UWS Director of Business Development, Iain Rothwell.

"We will cover topics such as new patent laws, marketing new technologies, exploring the latest financing options, how to commercialise IP and how to align business strategies with IP strategies."

For registration forms and more information, please contact Amanda Burdon on 9685 9845 or email a.burdon@uws.edu.au

WHERE: Sir Ian and Nancy Turbott Auditorium, UWS Parramatta campus, corner James Ruse Drive and Victoria Road, Rydalmere.

WHEN: Tuesday, July 2, 2002

TIME: 9am to 12.30pm

Ends.

Media contact: Suzie Vlaming, 9678 7429, email s.vlaming@uws.edu.au

Ends